The global 3D printing in healthcare market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2028, exhibiting a growth rate (CAGR) of 15.1% during 2023-2028. The increasing integration with imaging technologies, the rising collaborations between 3D printing companies and healthcare institutions, the growing potential for organ and tissue printing, and the easy accessibility of desktop 3D printers are some of the factors propelling the market.
|Market Size in 2022
||US$ 2.6 Billion
|Market Forecast in 2028
||US$ 6.5 Billion
|Market Growth Rate (2023-2028)
In healthcare, three-dimensional (3D) printing has emerged as a transformative technology with diverse applications. This cutting-edge technology is revolutionizing the field by enabling the development of surgical cutting tools, drill guides, and prosthetics. Additionally, it can craft patient-specific replicas of bones, organs, and blood vessels, facilitating precise surgical planning and training. Moreover, 3D printing is instrumental in regenerative medicine and tissue engineering, where it can create living human cells and tissues. This breakthrough paves the way for customized medical solutions, from tailored prosthetics to patient-specific drug formulations and equipment adaptations. One of its key advantages lies in reducing operative risks during intricate procedures, minimizing the likelihood of infections, and limiting the duration of anesthesia exposure. This not only enhances patient safety but also expedites recovery. Furthermore, 3D printing contributes to time and cost savings, streamlining the healthcare process and ensuring more efficient delivery of medical services. As a result, this technology is gaining remarkable traction across the global healthcare industry, offering unprecedented possibilities for innovation and personalized care. Its potential to transform healthcare as we know it is a testament to the ongoing advancements in medical technology.
The global market is majorly driven by the increasing advancements in 3D printing technology. In line with this, the customization of medical devices and implants and the rapid prototyping for medical research are significantly contributing to the market. Furthermore, the cost-effective production of complex anatomical models is positively influencing the market. Apart from this, the rising demand for patient-specific surgical guides and the growing prevalence of chronic diseases are catalyzing the market. Moreover, the escalating elderly population and the accelerating drug development and testing are propelling the market. Besides, enhanced surgical planning and training are strengthening the market. The increasing prosthetics and orthopedic applications and the rising production of biocompatible materials are fueling the market. Additionally, the regulatory support for medical 3D printing and the growing awareness among healthcare professionals are providing a boost to the market.
3D Printing in Healthcare Market Trends/Drivers:
Increasing need for regenerative medicines, stem cell solutions, and cancer therapeutics
The increasing need for regenerative medicines, stem cell solutions, and cancer therapeutics is bolstering the market. Regenerative medicine relies on precise tissue engineering and organ replication, where 3D printing excels. The ability to create patient-specific constructs with biocompatible materials aligns perfectly with regenerative medicine's goals, offering hope for those in need of tissue replacement or regeneration. Furthermore, stem cell solutions, often used for personalized treatment approaches, benefit from 3D printing's precision in creating custom scaffolds and structures that support cell growth and differentiation. Moreover, the development of cancer therapeutics increasingly involves 3D-printed models to mimic tumor environments. These models aid drug testing, ultimately leading to more effective and tailored cancer treatments.
Rising investments in research and development (R&D) activities
Rising research and development (R&D) investments create a positive market outlook. Investment in R&D often results in the development of cutting-edge technologies and innovations that can revolutionize industries. It allows companies to create new and improved products, stay competitive, and meet evolving customer demands. Research efforts can lead to more efficient production processes, reducing costs and resource consumption. It can help companies explore new markets, expand their product offerings, and reach a broader customer base. It can also lead to the development of eco-friendly technologies and practices, addressing environmental concerns. R&D funding drives medical discoveries in healthcare, leading to new treatments, drugs, and therapies. A robust R&D ecosystem can stimulate economic growth by creating jobs, fostering innovation, and attracting investment.
Expanding pharmaceutical applications
The expanding pharmaceutical applications of 3D printing are propelling significant growth in the healthcare market. This transformative factor is revolutionizing drug development and delivery by allowing for the precise customization of pharmaceuticals. With 3D printing, medications can be tailored to meet individual patient needs, resulting in more effective treatments and enhanced patient outcomes. Moreover, 3D printing facilitates the creation of complex drug delivery systems, enabling controlled release and improved drug efficacy. The technology's ability to rapidly prototype new drug formulations accelerates drug development, reducing time and costs. Additionally, the production of pediatric medications and specialized drugs for rare diseases is made more feasible and cost-effective through 3D printing. As regulatory bodies adapt to accommodate these innovations, the healthcare industry is witnessing a fundamental shift in pharmaceutical production and patient care, driving substantial market growth and promising a future of more personalized and efficient healthcare solutions.
3D Printing in Healthcare Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global 3D printing in healthcare market report, along with forecasts at the global, regional, and country levels for 2023-2028. Our report has categorized the market based on material, technology, application, and end user.
Breakup by Material:
Polymer dominates the market
The report has provided a detailed breakup and analysis of the market based on the material. This includes polymer, metals, ceramic, and organic. According to the report, polymer represented the largest segment.
Polymer-based 3D printing is instrumental in creating various medical devices, prosthetics, and customized implants. Biocompatible polymers like PLA and PEEK are widely used in creating patient-specific anatomical models and dental applications. Moreover, they are suitable materials for cost-effective prosthetic limbs and orthopedic implants, enhancing patient mobility and comfort.
On the other hand, metal 3D printing is revolutionizing the production of intricate and durable medical components. Titanium and stainless steel alloys are commonly employed in manufacturing orthopedic implants, cranial implants, and dental prosthetics. These metals offer exceptional strength and biocompatibility, ensuring the longevity and reliability of implanted devices. Additionally, metal 3D printing's precision allows for intricate lattice structures that promote osseointegration, enabling faster healing and improved patient outcomes.
Breakup by Technology:
- Droplet Deposition
- Fused Filament Fabrication (FFF) Technology
- Low-temperature Deposition Manufacturing (LDM)
- Multiphase Jet Solidification (MJS)
- Stereolithography (SLA)
- Continuous Liquid Interface Production (CLIP)
- Two-photon Polymerization (2PP)
- Laser Beam Melting
- Selective Laser Sintering (SLS)
- Selective Laser Melting (SLM)
- Direct Metal Laser Sintering (DMLS)
- Electronic Beam Melting (EBM)
- Laminated Object Manufacturing
Droplet deposition dominates the market
The report has provided a detailed breakup and analysis of the market based on the technology. This includes droplet deposition (fused filament fabrication (FFF) technology, low-temperature deposition manufacturing (LDM), multiphase jet solidification (MJS)), photopolymerization (stereolithography (SLA), continuous liquid interface production (CLIP), two-photon polymerization (2PP)), laser beam melting (selective laser sintering (SLS), selective laser melting (SLM), direct metal laser sintering (DMLS)), electronic beam melting (EBM), laminated object manufacturing, and others. According to the report, droplet deposition represented the largest segment.
Droplet Deposition technology, also known as Fused Deposition Modeling (FDM), is cost-effective and widely used for producing patient-specific anatomical models, custom prosthetics, and orthopedic implants. It offers versatility and accessibility, making it suitable for various healthcare applications, including educational purposes.
On the other hand, utilizing photoreactive polymers, photopolymerization, exemplified by stereolithography (SLA) and Digital Light Processing (DLP), excels in creating highly detailed and intricate medical models and dental devices. It enables the production of accurate prototypes, dental crowns, and surgical guides, supporting precise and personalized healthcare solutions.
Moreover, laser-based technologies like Selective Laser Sintering (SLS) and Direct Metal Laser Sintering (DMLS) are vital for manufacturing complex metal components such as orthopedic implants, prosthetics, and dental restorations. The exceptional accuracy and material strength provided by laser beam melting is essential for critical medical applications, ensuring durability and biocompatibility.
Breakup by Application:
- External Wearable Devices
- Hearing Aids
- Prosthesis and Orthotics
- Dental Products
- Clinical Study Devices
- Drug Testing
- Anatomical Models
- Surgical Guides
- Cranio-maxillofacial Implants
- Orthopedic Implants
- Tissue Engineering
External Wearable Devices dominates the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes external wearable devices (hearing aids, prosthesis and orthotics, dental products), clinical study devices (drug testing and anatomical models), implants (surgical guides, cranio-maxillofacial implants, and orthopedic implants), and tissue engineering. According to the report, external wearable devices represented the largest segment.
3D printing technology facilitates the production of custom-fit external wearable devices such as prosthetic limbs, orthopedic braces, and hearing aids. These personalized devices enhance patient comfort, mobility, and quality of life, driving growth in this segment.
On the contrary, 3D printing creates patient-specific models, surgical guides, and anatomical replicas in medical research and clinical trials. These devices are instrumental in enhancing surgical training, medical education, and preoperative planning, thus contributing to the growth of this segment.
Moreover, the production of implants, including orthopedic, dental, and cranial implants, is a critical application of 3D printing in healthcare. These patient-specific implants offer improved functionality, durability, and biocompatibility, driving significant growth in the market.
Breakup by End User:
- Medical and Surgical Centers
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
Medical and surgical centers dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions. According to the report, medical and surgical centers represented the largest segment.
Medical and surgical centers include hospitals, clinics, and specialized healthcare facilities. These institutions widely utilize 3D printing for applications such as patient-specific anatomical models, surgical guides, custom prosthetics, and orthopedic implants. The technology empowers healthcare providers with tools for precise diagnosis, treatment planning, and patient-specific interventions, enhancing overall patient care and surgical outcomes. The growing adoption of 3D printing in medical and surgical centers drives market growth by improving healthcare delivery.
Furthermore, the pharmaceutical and biotechnology sector leverages 3D printing for drug development, personalized medicine, and drug delivery systems. 3D-printed pills, tablets, and drug-loaded implants enable precise dosing, improved drug release profiles, and customized therapies. This segment fosters market growth by advancing drug development processes and enhancing the efficacy and safety of pharmaceutical products.
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, encompassing the United States and Canada, is a significant driver of growth in 3D printing in healthcare market due to several key factors. It is a hub for technological advancements and innovation, fostering the development and adoption of 3D printing in healthcare applications. The region boasts advanced healthcare facilities and research institutions that actively utilize 3D printing for patient-specific models, surgical planning, and medical device production. Regulatory bodies in North America have been receptive to 3D printing technologies in healthcare, expediting approvals for medical devices and implants.
Ongoing investment in research and development activities fuels continuous innovation and growth in 3D printing applications, benefiting both the medical and pharmaceutical sectors. The region is home to leading 3D printing companies and healthcare providers that drive market growth through collaborations and investments in cutting-edge technologies. Furthermore, patients increasingly seek personalized healthcare solutions, escalating the adoption of 3D printing for customized implants, prosthetics, and medical models.
Top companies are strengthening the market growth through their innovative approaches and unwavering commitment to advancing medical technology. These industry leaders are contributing to growth in several key ways. They are at the forefront of research and development, investing heavily in cutting-edge technologies that enhance the capabilities of 3D printing in healthcare. These innovations expand the scope of applications, from patient-specific implants to drug delivery systems. Top companies actively collaborate with healthcare institutions and research organizations to drive progress. These collaborations result in groundbreaking solutions and foster a deeper understanding of 3D printing's potential in medicine. They work closely with regulatory authorities to ensure compliance with evolving healthcare standards, facilitating the adoption of 3D-printed medical devices and pharmaceuticals. These companies invest in educational initiatives to train healthcare professionals to use 3D printing technology effectively. They contribute to global awareness, demonstrating the transformative impact of 3D printing in healthcare through case studies and success stories. Their dedication to pushing the boundaries of what's possible in the medical field ensures the continued growth and evolution of 3D printing in healthcare market.
The report has provided a comprehensive analysis of the competitive landscape of 3D printing in healthcare market. Detailed profiles of all major companies have also been provided.
- 3D Systems Inc.
- Desktop Metal Inc.
- EOS GmbH
- Materialise NV
- Organovo Holding Inc.
- Oxford Performance Materials Inc.
- Prodways Tech
- Proto Labs Inc.
- Renishaw plc
- SLM Solutions Group AG
- Stratasys Ltd
- In August 2023, 3D Systems, a prominent player in additive manufacturing solutions, and Theradaptive, a biopharmaceutical innovator specializing in targeted regenerative therapies, unveiled a commercial agreement. This partnership designates 3D Systems as the exclusive 3D printing collaborator for Theradaptive. Together, they are poised to introduce an innovative approach to stimulate bone and tissue growth.
- In July 2023, Desktop Health forged a strategic partnership with Carbon to introduce the Flexcera Family Resins to the Carbon Digital Manufacturing Platform. This collaboration represents a significant development in digital manufacturing and dental technology.
- In June 2023, EOS GmbH partnered with Tecomet, Inc., Precision ADM, and OIC to provide end-to-end medical device additive manufacturing solutions.
3D Printing in Healthcare Market Report Scope:
|Base Year of the Analysis
|Scope of the Report
||Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- End User
||Polymer, Metals, Ceramic, Organic
- Droplet Deposition: Fused Filament Fabrication (FFF) Technology, Low-temperature Deposition Manufacturing (LDM), Multiphase Jet Solidification (MJS)
- Photopolymerization: Stereolithography (SLA), Continuous Liquid Interface Production (CLIP), Two-photon Polymerization (2PP)
- Laser Beam Melting: Selective Laser Sintering (SLS), Selective Laser Melting (SLM), Direct Metal Laser Sintering (DMLS)
- Electronic Beam Melting (EBM)
- Laminated Object Manufacturing
- External Wearable Devices: Hearing Aids, Prosthesis and Orthotics, Dental Products
- Clinical Study Devices: Drug Testing, Anatomical Models
- Implants: Surgical Guides, Cranio-maxillofacial Implants, Orthopedic Implants
- Tissue Engineering
|End Users Covered
||Medical and Surgical Centers, Pharmaceutical and Biotechnology Companies, Academic Institutions
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||3D Systems Inc., Desktop Metal Inc., EOS GmbH, Formlabs, Materialise NV, Organovo Holding Inc., Oxford Performance Materials Inc., Prodways Tech, Proto Labs Inc., Renishaw plc, SLM Solutions Group AG, Stratasys Ltd., etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of 3D printing in healthcare market from 2017-2028.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global 3D printing in healthcare market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within 3D printing in healthcare industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.